Golden
Pfizer

Pfizer

Pfizer is an american multinational pharmaceutical corporation.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

August 21, 2019

Pfizer announces an additional half billion dollar investment for the construction of its gene therapy manufacturing facility in Sanford, North Carolina.

June 17, 2019

Pfizer acquires Array BioPharma for $11.4 billion.

Funded Companies

Company
Description
Website
Industry
Location

Cortexyme is a company developing novel treatments for Alzheimer's disease and other neurodegenerative disorders.

Molecular Stethoscope is a San Diego-based company.

Imara is a Cambridge, Massachusetts-based company.

Arrakis Therapeutics is a Waltham, Massachusetts-based company.

NextCure is a Beltsville, Maryland-based company.

7 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

A. Santiesteban

Employee



Abby Michaud

Employee



Abdalrahman Mekky, CMA

Employee



Abinaya A

Employee



Abiola Joseph

Employee



Abraham Svinkelstin, PMP, MS, MS, CSSGB

Employee



Adam Escalante

Employee



Adekunle Adeniran

Employee



Agnes Lei

Employee



AHMET ADIYAMAN

Employee



Aimee Greene

Employee



Aindréas MacDomhnaill

Employee



Aine Aherne

Employee



Akanqsha Shetty

Employee



Alba Hernandez

Employee



Alec Robert Gilarde

Employee



Alejandra Fonseca

Employee



Alekhya Reddy

Employee



Alex Haddad

Employee



Alexander H. Buell

Employee



Alexandra Grossbarth

Employee



Alexey Chapyshev

Employee



Alican Liceoglu

Employee



Alisha Dhiman

Employee



Alison Hanlon

Employee



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









News

Title
Author
Date
Publisher
Description
Ludwig Burger
February 24, 2020
U.S.
Private equity-backed generic drugmaker Stada said it has agreed to buy 15 consumer healthcare products from British drugmaker GlaxoSmithKline to further strengthen its prescription-free drugs business in Europe.
January 22, 2020
WebWire
On the opening of the World Economic Forum in Davos and as Gavi, the Vaccine Alliance, commemorates its twentieth year and launches a new fundraising appeal, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) calls on the global vaccine community to ensure that the 55 million children who lack access to the pneumonia vaccine are protected against this deadly disease, especially now that a new, more affordable vaccine is finally availa...
Bloomberg
January 15, 2020
@bsindia
Albert Bourla, CEO of Pfizer, discussed the time frame for the IPO at the JPMorgan Healthcare Conference in San Francisco on Tuesday
Lydia Ramsey
December 3, 2019
Business Insider
From enhancing drug discovery to building tools for employees, here are the priorities of the chief digital officers at Pfizer, CVS, and Novartis.
SI Reporter
December 2, 2019
@bsindia
Read more about MNC pharma shares in focus; Pfizer, Sanofi India, AstraZeneca hit new high on Business Standard. Novartis India rallied 7 per cent to Rs 709, while Abbott India gained 2 per cent to Rs 12,865 on the BSE.
Carl O'Donnell
November 27, 2019
U.S.
Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world's priciest medicines.
Reuters
October 30, 2019
@bsindia
Read more about Wall Street holds steady after S&P hits record; Merck, Pfizer stocks gain on Business Standard. The spread in the yield curve has gainedabout 20 basis points since leaving negative territory, a recession indicator, in early September
Reuters Editorial
October 29, 2019
U.S.
U.S. drugmaker Pfizer Inc raised its 2019 full-year earnings forecast on Tuesday, sending its shares up 3%.
Roni Caryn Rabin
October 14, 2019
www.nytimes.com
A critical chemotherapy medication is in short supply, and physicians say there is no appropriate substitute.
TrialSpark
September 17, 2019
www.prnewswire.com:443
NEW YORK, Sept. 17, 2019 /PRNewswire/ -- TrialSpark, a technology company committed to improving the speed, access, and reliability of clinical trials, and...
Research and Markets
September 13, 2019
www.prnewswire.com:443
DUBLIN, Sept. 13, 2019 /PRNewswire/ -- The "Pneumococcal Vaccines Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's...
August 21, 2019
AP NEWS
SANFORD, N.C. (AP) -- Drug giant Pfizer is expanding its North Carolina manufacturing plant for gene-therapy medicines to treat rare diseases, adding about 300 jobs.
August 21, 2019
WebWire
Pfizer announced today an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility is anticipated to support Pfizer's continuing investment in gene therapy research and development, similar to Pfizer's Chapel Hill and Kit Creek, North Carolina research and development sites. This facility would expand the company's presence in North Carolina, where there are currently more than 3,600...
July 29, 2019
www.nytimes.com
Officials from the two countries are meeting this week to continue working on a truce. But neither side seems eager for a speedy resolution.
By Michael J. de la Merced and Katie Thomas
July 28, 2019
www.nytimes.com
The drug company is near an agreement to combine the division, which includes Viagra and Lipitor, with the pharmaceutical company Mylan.
Sheila Kaplan
July 2, 2019
www.nytimes.com
The Democratic presidential candidate rebuked Dr. Scott Gottlieb, saying his decision to align with a major drug company "smacks of corruption."
Associated Press
June 17, 2019
Boston Herald
NEW YORK (AP) -- Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.
HEATHER MURPHY
May 11, 2019
www.nytimes.com
Over golf outings and at dinners, more than a dozen competitors agreed to keep prices for H.I.V., asthma and cancer drugs artificially high, 44 states allege in a new lawsuit.
Martinne Geller
April 4, 2019
U.S.
The United States and China will be key focuses for the consumer healthcare venture being formed by GlaxoSmithKline and Pfizer, as the companies look to build on strong existing positions in those markets.
JAMIE CONDLIFFE
December 19, 2018
www.nytimes.com
The new venture will own an array of popular pain relievers, toothpastes, cold treatments, vitamins and dietary supplements.
SHOW MORE

References